Results for tag: "Cannabinoid Agonist"

Cannabinoid agonists are drugs that interact with the endocannabinoid system, a network of receptors found throughout the central nervous system. These drugs are used to treat a variety of conditions, including pain, inflammation, anxiety, and depression. They are also used to treat neurological disorders such as epilepsy, multiple sclerosis, and Parkinson's disease. Cannabinoid agonists are typically administered orally, through inhalation, or through topical application. The cannabinoid agonist market is a rapidly growing segment of the central nervous system drugs market. It is driven by the increasing prevalence of neurological disorders, the growing acceptance of medical cannabis, and the development of novel cannabinoid-based therapies. The market is expected to continue to grow in the coming years, as more research is conducted and new treatments are developed. Some of the major companies in the cannabinoid agonist market include GW Pharmaceuticals, AbbVie, Insys Therapeutics, and Zynerba Pharmaceuticals. Show Less Read more